GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Price (Quote)

$1.23
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $1.23 $1.23 Friday, 27th May 2022 CTRV stock ended at $1.23. During the day the stock fluctuated 0% from a day low at $1.23 to a day high of $1.23.
90 days $0.94 $1.27
52 weeks $0.86 $2.32

Historical ContraVir Pharmaceuticals Inc prices

Date Open High Low Close Volume
2019-05-02 $0.160 $0.182 $0.140 $0.168 18 213 904
2019-05-01 $0.133 $0.188 $0.130 $0.160 45 460 194
2019-04-30 $0.120 $0.128 $0.113 $0.127 10 486 107
2019-04-29 $0.111 $0.117 $0.108 $0.113 5 699 300
2019-04-26 $0.120 $0.121 $0.103 $0.110 8 860 303
2019-04-25 $0.100 $0.118 $0.100 $0.115 32 995 848
2019-04-24 $0.212 $0.212 $0.200 $0.203 265 834
2019-04-23 $0.221 $0.221 $0.200 $0.200 511 580
2019-04-22 $0.220 $0.221 $0.205 $0.210 381 817
2019-04-18 $0.236 $0.236 $0.211 $0.228 298 170
2019-04-17 $0.244 $0.246 $0.228 $0.233 199 543
2019-04-16 $0.251 $0.251 $0.230 $0.235 414 499
2019-04-15 $0.252 $0.252 $0.240 $0.249 302 806
2019-04-12 $0.280 $0.286 $0.250 $0.258 672 222
2019-04-11 $0.242 $0.277 $0.230 $0.277 1 907 061
2019-04-10 $0.260 $0.260 $0.230 $0.233 431 714
2019-04-09 $0.250 $0.269 $0.230 $0.264 959 013
2019-04-08 $0.243 $0.250 $0.230 $0.237 500 606
2019-04-05 $0.268 $0.268 $0.240 $0.249 453 271
2019-04-04 $0.280 $0.280 $0.242 $0.260 509 577
2019-04-03 $0.278 $0.300 $0.260 $0.261 964 824
2019-04-02 $0.195 $0.340 $0.195 $0.278 3 433 447
2019-04-01 $0.228 $0.231 $0.185 $0.217 662 736
2019-03-29 $0.224 $0.229 $0.185 $0.225 354 217
2019-03-28 $0.230 $0.234 $0.210 $0.229 278 503
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT